Foghorn Therapeutics (FHTX) Assets Average (2020 - 2025)
Foghorn Therapeutics (FHTX) has 6 years of Assets Average data on record, last reported at $201.5 million in Q4 2025.
- For Q4 2025, Assets Average fell 31.96% year-over-year to $201.5 million; the TTM value through Dec 2025 reached $201.5 million, down 31.96%, while the annual FY2025 figure was $241.0 million, 15.41% down from the prior year.
- Assets Average reached $201.5 million in Q4 2025 per FHTX's latest filing, down from $215.6 million in the prior quarter.
- Across five years, Assets Average topped out at $504.0 million in Q1 2022 and bottomed at $197.3 million in Q3 2021.
- Average Assets Average over 5 years is $316.6 million, with a median of $297.9 million recorded in 2023.
- Peak YoY movement for Assets Average: skyrocketed 125.76% in 2022, then crashed 32.3% in 2025.
- A 5-year view of Assets Average shows it stood at $352.9 million in 2021, then increased by 18.84% to $419.4 million in 2022, then decreased by 28.55% to $299.7 million in 2023, then dropped by 1.17% to $296.2 million in 2024, then crashed by 31.96% to $201.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $201.5 million in Q4 2025, $215.6 million in Q3 2025, and $242.5 million in Q2 2025.